Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: A multicenter case-control study

American Journal of Medical Genetics, Part A

Volumn 146, Issue 9, 2008, Pages 1128-1133

  Candito, Mirande ^a   Rivet, Romain ^b   Herbeth, Bernard ^c   Boisson, Catherine ^d   Rudigoz, René Charles ^d   Luton, Dominique ^e   Journel, Hubert ^f   Oury, Jean François ^e   Roux, François ^g   Saura, Robert ^h   Vernhet, Isabelle ^h   Gaucherand, Pascal ⁱ   Muller, Françoise ^e   Guidicelli, Béatrice ^g   Heckenroth, Hélène ^g   Poulain, Patrice ^j   Blayau, Martine ^j   Francannet, Christine ^k   Roszyk, Laurence ^k   Brustié, Cécile ^a   Staccini, Pascal ^l   Gérard, Philippe ^b   Fillion Emery, Nathalie ^b   Guéant Rodriguez, Rosa Maria ^b,c   Van Obberghen, Emmanuel ^a   Guéant, Jean Louis ^b,c   more..

^a PASTEUR HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f CHU   (France)

^g TIMONE HOSPITAL   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ EDOUARD HERRIOT HOSPITAL   (France)

^j Hotel Dieu CHU Rennes   (France)

^k HÔTEL DIEU   (France)

^l CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

more..

Author keywords

Folate; Homocysteine; MTHFR; MTR; MTRR; Neural tube defects; Polymorphisms; TCN2; Vitamin B12; Vitamin B6

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; VITAMIN B GROUP;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEURAL TUBE DEFECT; NUTRITIONAL STATUS; PRIORITY JOURNAL; VITAMIN METABOLISM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; FRANCE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; NUTRITIONAL STATUS; POLYMORPHISM, GENETIC; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN B COMPLEX;

EID: 43049104999     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32199     Document Type: Article

References (27)

1. Afman LA, Van der Put NM, Thomas CM, Trijbels JM, Blom HJ. 2001. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. Q J Med 94:159-166.
2. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. 1992. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 22:79-87.
3. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
4. Busby A, Abramsky L, Dolk H, Armstrong B, Addor M, Anneren G, Armstrong N, Baguette A, Barisic I, Berghold A, Bianca S, Braz P, Calzolari E, Christiansen M, Cocchi G, Daltveit A, De Walle H, Edwards G, Gatt M, Gener B, Gillerot Y, Gjergja R, Goujard J, Haeusler M, Latos-Bielenska A, McDonnell R, Neuville A, Olars B, Portillo I, Rivanen A, Robert-Gnansia E, Rosch C, Scarano G, Steinbicker V. 2005. Preventing neural tube defects in Europe: A missed opportunity. Reprod Toxicol 20:393-402.
5. Carter CO. 1974. Clues to the aetiology of neural tube malformations. Dev Med Child Neurol 16:3-15.
6. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
7. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnel RH, Zhu H, Andreussi L, Cama A, Capra V. 2002. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47:319-324.
8. De Wals P, Tairou F, Van Allen M, Uh SH, Lowry B, Sibbald B, Evans J, Van den Hof M, Zmmer P, Crowley, Fernandez M, Lee N, Niyonsenga T. 2007. Reduction in neural- tube defects after folic acid fortification in Canada. N Engl J Med 357:135-142.
9. Fowler B. 1997. Disorders of homocysteine metabolism. J Inherit Metab Dis 20:270-285.
10. Gueant JL, Gueant-Rodriguez RM, Anello G, Bosco P, Brunaud L, Romano C, Ferri R, Romano A, Candito M, Namour B. 2003. Genetic determinants of folate and vitamin B12 metabolism: A common pathway in neural tube defects and Down syndrome? Clin Chem Lab Med 41:1473-1477.
11. Gueant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romano A, Anello G, Bosco P, Debard R, Gerard P, Viola M, Salvaggio E, Gueant JL. 2003. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 344:189-192.
12. Honein MA, Paulozzi FJ, Mathews T, Erickson J, Wong L-Y. 2001. Impact of folic acid fortification of the US food supply on the occurence of neural tube defects. JAMA 285:2981-2986.
13. Kessler DA, Shalala DE. 1996. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 8761-8797.
14. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86:703-708.
15. Kirke P, Mills J, Molloy A, Brody L, O'Leary V, Daly L, Murray S, Conley M, Mayne P, Smith O, Scott J. 2004. Impact of the MTHFR C677T polymorphism on the risk of neural tube defect case control study. BMJ 328:1535-1536.
16. Liu S, West R, Randell E, Longerich L, O'Connor K, Scott H, Crowley M, Lam A, Prabhakaran V, Mc Court C. 2004. A comprehensive evaluation of food fortification with folic acid in the primary prevention of neural tube defects. BMC Pregnancy Childbirth. 27:20.
17. Mills JL, McPartlin JM, Kirke PN, Lee Y, Conley M, Weir D, Scott J. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
18. MRC, Vitamin Study Research Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-1.37.
19. Namour F, Olivier J, Abdelmouttaleb I, Adjalla C, Debard R, Salvat C, Gueant J. 2001. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: Relation to transcobalamin and homocysteine concentration in blood. Blood 97:1092-1098.
20. O'Leary VB, Mills JL, Pangilinan F, Kirke P, Cox C, Conley M, Weiller A, Peng KJ, Shane B, Scott J, Parle-McDermott A, Molloy AM, Brody L. 2005. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 85:220-227.
21. Papapetrou C, Lynch SA, Burn J, Edwards YH. 1996. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
22. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy A, Burke H, Weir D, Scott J, Whitehead A. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
23. Thorand B, Pietrzik K, Prinz-Langenohl R, Hages M, Holzgreve W. 1996. Maternal and fetal serum and red blood cell folate and vitamin B12 concentrations in pregnancies affected by neural tube defects. Z Geburtshilfe Neonatol 200:176-180.
24. Van der Put NM, van der Molen EF, Kluijtmans LA, Heil S, Trijbels J, Eskes T, van Oppenraaij-Emmerzaal D, Barnerjee R, Blom H. 1997a. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med 90:511-517.
25. Van der Put NM, Eskes TK, Blom HJ. 1997b. Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J M 90:111-115.
26. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel R, Rozen R. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67:317-323.
27. Yamada K, Chen Z, Rozen R, Matthews RG. 2001. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98:14853-14858.